NVOH Performance — Novo Nordisk A/S (B Shares) ADRhedged
Data updated: 2026-08-21
NVOH returned −0.22% year to date and −23.84% over one year to Jun 2026. Over one year the fund trailed its Europe Health Care Equity category average: $100 grew to $76, against $125 for the category. Volatility over the past 12 months was 57.52% a year. In the 12 months to Jun 2026 the fund took in a net $4.1M, and assets reached $4.17M.
NVOH Growth of $100
What $100 invested in Novo Nordisk A/S (B Shares) ADRhedged grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Health Care Equity category average over the same months.
| Period | NVOH | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $76 | $125 |
| Since data start (Jan 2025 – Jun 2026) | $56 | $115 |
NVOH Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −0.22% |
| 1 year | −23.84% |
NVOH Annual Returns
Calendar-year total returns of Novo Nordisk A/S (B Shares) ADRhedged, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | −0.22% |
| 2025 | −44.02% |
NVOH Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +15.1% | −35.8% | +3.5% | +12.3% | +8.4% | +7.2% | — | — | — | — | — | — |
| 2025 | −0.5% | +7.0% | −24.8% | −8.9% | +7.6% | −6.5% | −29.0% | +18.0% | −1.8% | −8.7% | −0.5% | +2.1% |
NVOH Risk
Risk measures from monthly returns over Jul 2025 – Jun 2026.
- 1-year volatility (annualised): 57.52%
- Best month: +17.97% (Aug 2025)
- Worst month: −35.80% (Feb 2026)
NVOH Fund Flows
Monthly money in and out of Novo Nordisk A/S (B Shares) ADRhedged, from SEC Form N-PORT.
- 12-month net flow: $4.1M
- 12-month gross sales (incl. reinvestments): $5.1M
- Sales ÷ redemptions: 4.98×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $0 | $518K | −$518K |
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $206K | $222K | −$16K |
| Mar 2026 | $423K | $0 | $423K |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $1.6M | $0 | $1.6M |
| Dec 2025 | $823K | $0 | $823K |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $608K | $0 | $608K |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $1.1M | $283K | $814K |
| Jul 2025 | $368K | $0 | $368K |
NVOH Assets Under Management
Net assets of Novo Nordisk A/S (B Shares) ADRhedged by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $4.17M |
| 2026-03-31 | $3.71M |
| 2025-12-31 | $3.01M |
| 2025-09-30 | $1.80M |
| 2025-06-30 | $733.45K |
| 2025-03-31 | $800.53K |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.